Why is Ipca Labs falling/rising?

As of 21-Jul, Ipca Laboratories Ltd is currently priced at 1,464.20, reflecting a decrease of 7.8 points or 0.53%. The stock has been experiencing a downward trend, having lost 0.78% over the last two days. Despite this recent decline, the stock has shown a positive performance over the past month, with a return of 6.67%. It has also outperformed the benchmark index over the past year, generating a return of 22.82% compared to the Sensex's 1.98%. However, the stock's delivery volume has significantly decreased, falling by 48.73% against the 5-day average, indicating a decline in investor participation. Additionally, while the stock is trading above its shorter-term moving averages, it remains below its 200-day moving average, which may signal a bearish sentiment. In the broader market context, the stock's recent performance contrasts with the benchmark, as it has shown a positive return over the last month while the Sensex has slightly declined by 0.25%. Despite the current price drop, the company has demonstrated strong fundamentals, including a low debt-to-equity ratio and consistent positive results over the last four quarters, with a significant growth in profit after tax. High institutional holdings at 46.87% suggest that knowledgeable investors are backing the stock, which could provide some stability. However, the recent decline in trading volume and consecutive price falls may indicate a cautious sentiment among retail investors, contributing to the stock's current downward movement.